THERAPEUTIC AREA COMPOUND INDICATION PRE-CLINICAL CLINICAL
    ONCOLOGY CLX-ONC-55 Colorectal Cancer
  • CLX-ONC-551 Breast Cancer
  • CLX-ONC-17 Oral Mucositis
  • CLX-ONC-57 Familial adenomatous polyposis (FAP)
  • CLX-ONC-643 Malignant Gliomas
  • CLX-ONC-552 Solid Tumors
  • OPHTHALMOLOGY CLX-OPH-56 Glaucoma
  • CLX-OPH-561 Presbyopia
  • CLX-OPH-62 Glaucoma
  • CLX-OPH-621 Dry Eye
  • CLX-OPH-622 Ocular Redness
  • CLX-OPH-623 GVHD
  • CLX-OPH-624 Ocular Redness
  • CLX-OPH-65 Cataract
  • CLX-OPH-651 Glaucoma
  • CLX-OPH-652 Glaucoma
  • CNS CLX-CNS-04 Epilepsy
  • CLX-CNS-06 Multiple Sclerosis
  • CLX-CNX-07 Parkinson’s Disease
  • CLX-CNS-61 Major Depressive Disorder
  • GASTROINTESTINAL CLX-GI-03 Ulcerative Colitis
  • CLX-GI-31 Paediatric Ulcerative Colitis
  • CLX-GI-32 Ulcerative Colitis
  • INFECTIOUS DISEASES CLX-IFN-59 Systemic Fungal Infections
  • METABOLIC DISEASES CLX-MET-101 Diabetes and Lipid Disorders
  • DERMATOLOGY CLX-DER-621 Rosacea
  • CLX-DER-64 Acne
  • CLX-DER-622 Rosacea
  • CLX-DER-623 Rosacea